McKesson (MCK) Competitors

McKesson (NYSE:MCK) and Cencora (NYSE:COR) are both large-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, risk, community ranking, earnings, valuation, media sentiment, profitability, analyst recommendations and dividends.

Does the media favor MCK or COR?

In the previous week, Cencora had 2 more articles in the media than McKesson. MarketBeat recorded 36 mentions for Cencora and 34 mentions for McKesson. McKesson's average media sentiment score of 1.51 beat Cencora's score of 1.50 indicating that McKesson is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
McKesson	31 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Cencora	29 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Do insiders & institutionals have more ownership in MCK or COR?

85.1% of McKesson shares are owned by institutional investors. Comparatively, 97.5% of Cencora shares are owned by institutional investors. 0.1% of McKesson shares are owned by insiders. Comparatively, 10.8% of Cencora shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Is MCK or COR more profitable?

McKesson has a net margin of 0.82% compared to Cencora's net margin of 0.46%. Cencora's return on equity of 328.62% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
McKesson	0.82%	-181.26%	5.34%
Cencora	0.46%	328.62%	4.23%

Do analysts recommend MCK or COR?

McKesson currently has a consensus price target of $686.69, suggesting a potential downside of 4.50%. Cencora has a consensus price target of $301.18, suggesting a potential upside of 2.87%. Given Cencora's higher probable upside, analysts plainly believe Cencora is more favorable than McKesson.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
McKesson	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.87
Cencora	0 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.80

Does the MarketBeat Community prefer MCK or COR?

McKesson received 229 more outperform votes than Cencora when rated by MarketBeat users. Likewise, 74.28% of users gave McKesson an outperform vote while only 65.27% of users gave Cencora an outperform vote.

Company	Underperform	Outperform
McKesson	Outperform Votes 979 74.28%	Underperform Votes 339 25.72%
Cencora	Outperform Votes 750 65.27%	Underperform Votes 399 34.73%

Is MCK or COR a better dividend stock?

McKesson pays an annual dividend of $2.84 per share and has a dividend yield of 0.4%. Cencora pays an annual dividend of $2.20 per share and has a dividend yield of 0.8%. McKesson pays out 11.0% of its earnings in the form of a dividend. Cencora pays out 25.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. McKesson has increased its dividend for 17 consecutive years and Cencora has increased its dividend for 15 consecutive years.

Which has more risk & volatility, MCK or COR?

McKesson has a beta of 0.53, suggesting that its stock price is 47% less volatile than the S&P 500. Comparatively, Cencora has a beta of 0.6, suggesting that its stock price is 40% less volatile than the S&P 500.

Which has preferable earnings and valuation, MCK or COR?

McKesson has higher revenue and earnings than Cencora. McKesson is trading at a lower price-to-earnings ratio than Cencora, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
McKesson	$359.05B	0.25	$3.00B	$25.83	27.84
Cencora	$638.56M	88.86	$1.51B	$8.62	33.96

Summary

McKesson beats Cencora on 13 of the 22 factors compared between the two stocks.